Dogwood Therapeutics, Inc. Financial Flexibility Index
Dogwood Therapeutics, Inc. financial flexibility index. Dogwood Therapeutics, Inc. (DWTX) has a Financial Flexibility Index of -0.22x as of September 2025. Free cash flow of $-3.27 Million (operating CF $-3.27 Million minus capex $2.00) represents 0% of total liabilities ($14.61 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Dogwood Therapeutics, Inc. (2018–2024)
Financial flexibility index of Dogwood Therapeutics, Inc. from 2018 to 2024. Historical Financial Flexibility Index trend for Dogwood Therapeutics, Inc. across 7 annual periods. Explore DWTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Dogwood Therapeutics, Inc. Financial Flexibility Index by Year (2018–2024)
Dogwood Therapeutics, Inc. financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Dogwood Therapeutics, Inc.. For the full cash flow conversion analysis, see Dogwood Therapeutics, Inc. (DWTX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.29x | $-8.79 Million | $-8.79 Million | $30.03 Million | ▲ +97.8% |
| 2023 | -13.58x | $-4.87 Million | $-4.87 Million | $358.55K | ▼ -23.6% |
| 2022 | -10.99x | $-11.47 Million | $-11.47 Million | $1.04 Million | ▲ +10.6% |
| 2021 | -12.30x | $-15.69 Million | $-15.69 Million | $1.28 Million | ▼ -383.7% |
| 2020 | -2.54x | $-3.90 Million | $-3.90 Million | $1.53 Million | ▼ -539.1% |
| 2019 | -0.40x | $-2.09 Million | $-2.09 Million | $5.26 Million | ▲ +55.9% |
| 2018 | -0.90x | $-1.20 Million | $-1.20 Million | $1.33 Million | — |